BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
2 | 1012.65 | 1014.95 | 63 |
20 | 1010.65 | 1015.00 | 86 |
60 | 1010.00 | 1017.45 | 5 |
18 | 1009.00 | 1018.00 | 1 |
89 | 1008.00 | 1019.00 | 15 |
977 | Total | Total | 6814 |
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
2 | 1012.65 | 1014.95 | 63 |
20 | 1010.65 | 1015.00 | 86 |
60 | 1010.00 | 1017.45 | 5 |
18 | 1009.00 | 1018.00 | 1 |
89 | 1008.00 | 1019.00 | 15 |
977 | Total | Total | 6814 |
(OI , PRICE )
Stock with medium financial performance with average price momentum and val
Open | 1,011.00 |
Previous Close | 1,007.35 |
Volume | 650,772.00 |
Value (Lacs) | 6,618.35 |
VWAP | 1,017.44 |
Beta |
High | 1,024.95 |
Low | 1,008.00 |
UC Limit | 1,104.75 |
LC Limit | 903.95 |
52 Week High | 1,024.95 |
52 Week Low | 397.20 |
TTM EPS See historical trend | 39.69 (+10.15% YoY) |
TTM PE See historical trend | 25.62 (High PE) |
P/B See historical trend | 2.23 (Average P/B) |
Face Value | 1.00 |
Mkt Cap (Rs. Cr.) | 59,590 |
Dividend Yield | 0.30 |
20D Avg Volume | 2,184,193 |
20D Avg Delivery(%) | -- |
Sector PE | 45.96 |
Book Value Per Share | 458.07 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
Neutral Aurobindo Pharma; target of Rs 970: Motilal Oswal Nov 16 2023 03:50 PM
Aurobindo Pharm Standalone September 2023 Net Sales at Rs 2,668.76 crore, down 11.8% Y-o-Y Nov 10 2023 11:16 AM
Aurobindo Pharma Q2 results: Net profit jumps 85% to Rs 757 crore Nov 09 2023 08:34 PM
Aurobindo Pharma's arm gets FDA nod for hypogonadism drug Oct 23 2023 01:29 PM
Qty 297308 | Price 489.3 | % Traded 0.05 |
Qty 297308 | Price 489.3 | % Traded 0.05 |
Qty 297309 | Price 557.3 | % Traded 0.05 |
Qty 297309 | Price 557.3 | % Traded 0.05 |
Qty 277213 | Price 524.5 | % Traded 0.05 |
Qty 277213 | Price 524.5 | % Traded 0.05 |
Qty 435602 | Price 514.05 | % Traded 0.07 |
Qty 435602 | Price 514.05 | % Traded 0.07 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 8660510 | Price 849.3 | % Traded 1.48 |
Qty 2360231 | Price 875.94 | % Traded 0.40 |
Qty 1475687 | Price 670.51 | % Traded 0.25 |
Qty 1732500 | Price 669.92 | % Traded 0.30 |
Qty 1940000 | Price 180.97 | % Traded 0.33 |
Qty 1500000 | Price 172.99 | % Traded 0.26 |
Qty 2353228 | Price 173.03 | % Traded 0.40 |
Qty 375750 | Price 1037.53 | % Traded 0.06 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Qty 2000000 | Price 900.95 | % Traded 0.34 | Post Tnx Hold. 33.51% |
Qty 6000 | Price 922.07 | % Traded 0.00 | Post Tnx Hold. 0.03% |
Qty 1096 | Price 913 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 3000000 | Price 873.6 | % Traded 0.51 | Post Tnx Hold. 33.51% |
Qty 5000 | Price 927 | % Traded 0.00 | Post Tnx Hold. 0.05% |
Qty 1800 | Price 907.31 | % Traded 0.00 | Post Tnx Hold. 0% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
Qty 79000 | Price 0 | % Traded 0.00 | Post Tnx Hold. 5.01% |
Qty 130000 | Price 0 | % Traded 0.02 | Post Tnx Hold. 0.02% |
Qty 130000 | Price 0 | % Traded 0.02 | Post Tnx Hold. 0% |
Qty 11892836 | Price 0 | % Traded 2.03 | Post Tnx Hold. 3.08% |
Qty 600000 | Price 0 | % Traded 0.10 | Post Tnx Hold. 1.19% |
Qty 11774855 | Price 0 | % Traded 2.01 | Post Tnx Hold. 5.11% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Aurobindo Pharm | 1,007.35 | 3.15 | 59,024.53 | 25.38 | 2.40 | 7.18 | 112.36 | 1,939 | 24,855 | 0.18 |
Sun Pharma | 1,194.60 | 0.42 | 286,624.56 | 33.53 | 5.61 | 15.13 | 17.89 | 8,560 | 43,885 | 0.11 |
Cipla | 1,249.40 | 1.18 | 100,867.24 | 29.25 | 4.77 | 11.96 | 11.60 | 2,835 | 22,753 | 0.02 |
Divis Labs | 3,600.85 | 1.48 | 95,591.25 | 71.77 | 8.15 | 14.28 | 9.45 | 1,823 | 7,767 | 0.00 |
Dr Reddys Labs | 5,611.55 | 1.21 | 93,598.89 | 18.38 | 4.86 | 19.35 | 26.92 | 4,470 | 24,669 | 0.05 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>